Fig. 4
From: Long-term prophylaxis with lanadelumab for HAE: authorization for temporary use in France
Overview of physician-confirmed hereditary angioedema (HAE) attacks and use of on-demand treatment. Attacks with a green asterisk are treated attacks. The red asterisks correspond to the day of last follow-up for each patient. HAE attack data are reported for 21 of 22 patients who had an attack after D0, as data for attack dates were missing for one patient. All patients who experienced attacks after D0 had received lanadelumab 300 mg every 2 weeks. Although 3 patients underwent dosage modifications, the modifications took place several days after the occurrence of the latest HAE attack. D day, ID identification